Homepage Free Drug Screen PDF Template
Outline

In the realm of employment and regulatory compliance, the Federal Drug Testing Custody and Control Form stands as a critical document, meticulously designed to oversee the integrity of the drug testing process from collection to analysis. This multi-step form, which includes the involvement of various stakeholders—employers, collection sites, and laboratories—ensures a meticulous audit trail for the specimen's journey. Quest Diagnostics, a prominent entity in the medical testing field, marks its endorsement through the acquisition of unique identifiers like the Specimen ID No. and Lab Accession No., signifying the company's integral role in the drug testing ecosystem. The form features explicit sections dedicated to capturing essential information, ranging from employer details, the Medical Review Officer (MRO)'s contact information, to the donor's identification, underlining the operation's high stakes in terms of privacy and accuracy. Distinct scenarios prompting the test, such as pre-employment screening and post-accident analysis, highlight the versatility and necessity of the form across diverse circumstances. Moreover, the inclusion of specific drugs to be screened—THC, COC, PCP, OPI, AMP—underscores the meticulous approach to detecting substance abuse, whereas the step-by-step guidance to collectors and detailed reporting requirements imposed on laboratories underscore the form's role in ensuring the reliability and legality of the drug testing process. Hence, the Federal Drug Testing Custody and Control Form represents more than just paperwork; it is a cornerstone of ethical labor practices, legal compliance, and the safeguarding of workplace safety and public trust.

Document Preview

FEDERAL DRUG TESTING CUSTODY AND CONTROL FORM

800-877-7484

SPECIMEN ID NO.

 

STEP 1: COMPLETED BY COLLECTOR OR EMPLOYER REPRESENTATIVE

LAB ACCESSION NO.

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics Incorporated. © Quest Diagnostics Incorporated. All rights reserved. QD20315-FED. Revised 10/10. SC2K - 111192.

A. Employer Name, Address, I.D. No.

 

 

B. MRO Name, Address, Phone and Fax No.

 

 

 

 

 

 

 

 

 

C. Donor SSN or Employee I.D. No. _______________________________________________________________

 

 

 

 

D. SpecifyTesting Authority: HHS

NRC

DOT – Specify DOT Agency: FMCSA

FAA

FRA FTA PHMSA USCG

E. Reason forTest: Pre-employment

Random

Reasonable Suspicion Cause Post Accident

Return to Duty

Follow-up Other (specify) ____________________________

F. DrugTests to be Performed:

THC, COC, PCP, OPI, AMP

THC & COC Only

Other (specify) ________________________________________________

G. Collection Site Name:

 

 

 

 

 

Collection Site Code:

 

 

 

 

Address:

 

 

 

 

 

 

Collector Phone No.:

 

 

City, State and Zip:

 

 

 

 

 

Collector Fax No.:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STEP 2: COMPLETED BY COLLECTOR (make remarks when appropriate) Collector reads specimen temperature within 4 minutes.

Temperature between 90° and 100° F? Yes No, Enter Remark

Collection: Split Single None Provided, Enter Remark

Observed, (Enter Remark)

REMARKS

STEP 3: Collector affixes bottle seal(s) to bottle(s). Collector dates seal(s). Donor initials seal(s). Donor completes STEP 5 on Copy 2 (MRO Copy)

STEP 4: CHAIN OF CUSTODY - INITIATED BY COLLECTOR AND COMPLETED BY TEST FACILITY

 

I certify that the specimen given to me by the donor identified in the certification section on Copy 2 of this form was

 

SPECIMEN BOTTLE(S) RELEASED TO:

 

collected, labeled, sealed, and released to the Delivery Service noted in accordance with applicable Federal requirements.

Quest Diagnostics Courier

 

 

X

 

 

 

 

 

FedEx

 

 

Signature of Collector

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AM

 

 

 

 

 

 

 

 

 

PM

 

 

 

 

 

(Print) Collector's Name (First, MI, Last)

Date (Mo./Day/Yr.)

 

Time of Collection

 

 

Name of Delivery Service

RECEIVED AT LAB OR IITF:

 

 

 

 

 

Primary Specimen

SPECIMEN BOTTLE(S) RELEASED TO:

 

X

 

 

 

 

 

Bottle Seal Intact

 

 

 

 

 

 

 

Yes No

 

 

 

Signature of Accessioner

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

If No, Enter remarks

 

 

 

 

 

 

 

 

 

in Step 5A.

 

 

 

(Print) Accessioner’s Name (First, MI, Last)

 

 

 

Date (Mo./Day/Yr.)

 

STEP 5A: PRIMARY SPECIMEN REPORT - COMPLETED BY TEST FACILITY

NEGATIVE

POSITIVE for:

Marijuana Metabolite ( 9-THCA)

6- Acetylmorphine

Methamphetamine

MDMA

DILUTE

 

 

Cocaine Metabolite (BZE)

Morphine

Amphetamine

MDA

 

 

 

PCP

Codeine

 

MDEA

REJECTED FOR TESTING

ADULTERATED

SUBSTITUTED

INVALID RESULT

 

 

REMARKS:

Test Facility (if different from above):

I certify that the specimen identified on this form was examined upon receipt, handled using chain of custody procedures, analyzed, and reported in accordance with applicable Federal requirements.

X

Signature of Certifying Scientist

(Print) Certifying Scientist's Name (First, MI, Last)

Date (Mo./Day/Yr.)

STEP 5b: COMPLETED BY SPLIT TESTING LABORATORY

RECONFIRMED FAILED TO RECONFIRM - REASON ____________________________________________

___________________________________________

I certify that the split specimen identified on this form was examined upon receipt, handled using chain of custody

procedures, analyzed and reported in accordance with applicable Federal requirements.

 

 

 

 

 

 

 

 

 

 

 

 

Laboratory Name

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

___________________________________________

X

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Signature of Certifying Scientist

 

 

 

(Print) Certifying Scientist's Name (First, MI, Last)

Date (Mo./Day/Yr.)

 

 

 

 

 

 

 

Laboratory Address

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OMB No. 0930-0158

PRESS HARD - YOU ARE MAKING MULTIPLE COPIES

Document Attributes

Fact Name Detail
Governing Laws and Agencies The form specifies testing authority including HHS, NRC, and DOT with specific DOT agencies like FMCSA, FAA, FRA, FTA, PHMSA, and USCG.
Reasons for Testing Outlined reasons for drug tests include Pre-employment, Random, Reasonable Suspicion/Cause, Post Accident, Return to Duty, Follow-up, and others to be specified.
Types of Drug Tests The form lists specific substances to be tested for, including THC, COC, PCP, OPI, AMP among others, providing an option for additional substances to be specified.
Chain of Custody Procedure The form details a meticulous chain of custody procedure initiated by the collector and completed by the testing facility to ensure integrity and security of the specimen.

How to Fill Out Drug Screen

Once you've been asked to complete a Drug Screen form, it's crucial to fill it out correctly to ensure accuracy and compliance with federal guidelines. This form is essential for documenting the process of collecting and testing a specimen for drugs. The step-by-step guide below will help you navigate through the form efficiently, ensuring every necessary detail is accounted for.

  1. Start with Step 1, which should be completed by the collector or the employer representative. Fill in the Employer Name, Address, I.D. No. in the designated area.
  2. Next, provide the MRO (Medical Review Officer) Name, Address, Phone and Fax No. This is crucial for ensuring the results are sent to the right medical professional for review.
  3. Enter the Donor SSN or Employee I.D. No. to uniquely identify the individual providing the specimen.
  4. Under Specify Testing Authority, choose the appropriate authority like HHS, NRC, DOT and specify the DOT agency if applicable.
  5. Select the Reason for Test from the available options, such as Pre-employment, Random, or Reasonable Suspicion Cause, among others. If the reason doesn't fit any listed categories, use the "Other" option and specify.
  6. In the section for Drug Tests to be Performed, mark the types of drugs to be screened. Choices include THC, COC, PCP, OPI, AMP among others. Again, if you need to specify other tests, use the provided line.
  7. Fill out the Collection Site details, including the Name, Code, Address, Phone No., Collector Fax No., City, State, and Zip.
  8. Move to Step 2, where the collector fills out specifics like specimen temperature, collection type, and any remarks if necessary.
  9. In Step 3, the collector affixes the bottle seal(s), dates them, and obtains the donor's initials on the seal(s).
  10. Step 4 details the chain of custody, initiated by the collector and completed by the test facility. It includes the collector's signature, name, the date and time of collection, and the name of the delivery service.
  11. For Step 5, wait for the results from the test facility. If there's any remark or specific outcome, it will be listed under Step 5a or 5b, as completed by the respective facility.

After completing the form, ensure all copies are distributed as required, with each party receiving their designated copy. This form serves as a crucial part of the drug testing process, allowing for a clear and consistent documentation trail from collection to result analysis.

More About Drug Screen

Frequently Asked Questions about the Drug Screen Form:

  1. What is a Federal Drug Testing Custody and Control Form?

    This form is a crucial document in the drug testing process, ensuring that the specimen collection and testing are done under strict guidelines to maintain chain of custody. It ensures the specimen's integrity from collection through to analysis, following federal requirements.

  2. Who completes the Drug Screen Form?

    The form is filled out in multiple steps by different individuals: a collector or employer representative, the collector at the collection site, and finally by personnel at the testing facility. Each plays an important role in maintaining the specimen’s chain of custody and integrity.

  3. What information is required from the donor?

    The donor must provide their Social Security Number (SSN) or Employee Identification Number (EID), initial the specimen bottle seal, and complete part of the MRO (Medical Review Officer) Copy of the form. This information helps in accurately identifying and processing the specimen.

  4. How are drug tests specified on the form?

    The form allows the employer to specify which drugs to test for, such as THC, COC, PCP, OPI, AMP, among others, or simply THC & COC. This selection is vital for the testing lab to understand what analyses to perform.

  5. What does the temperature check imply?

    Within 4 minutes of collection, the collector checks the specimen’s temperature to ensure it’s between 90° and 100° F. This step verifies the specimen's validity, indicating it was genuinely provided by the donor at the time of collection.

  6. What happens if the specimen fails quality control at the lab?

    If a specimen is adulterated, substituted, invalid, or if the seal is not intact, it may be rejected for testing, with remarks entered by the lab personnel. These actions are crucial for ensuring the reliability of the test results.

  7. What does a split specimen mean?

    A split specimen means the donor’s sample is divided into two bottles, one for initial testing and the other for a confirmation test if needed. This process is part of maintaining fairness and accuracy in drug testing.

  8. What is the role of the Medical Review Officer (MRO)?

    The MRO is a licensed physician responsible for receiving and reviewing laboratory results generated by an employer's drug testing program. The MRO ensures the accuracy of the test results and provides an additional level of scrutiny to protect the rights of the individual being tested.

  9. How is confidentiality ensured in the drug testing process?

    Confidentiality is of utmost importance throughout the drug testing process. The use of ID numbers, secure handling procedures, and strict access controls to test results help protect the privacy of individuals. Only authorized personnel have access to the test results, ensuring personal information is safeguarded.

Common mistakes

When individuals or employers fill out the Federal Drug Testing Custody and Control Form, accuracy and completeness are crucial for ensuring the integrity of the testing process. However, several common mistakes can compromise the efficacy of the drug screening procedure. Recognizing and avoiding these pitfalls is vital for all parties involved.

  1. Failing to provide complete information for the employer, including the name, address, and identification number. This oversight can lead to confusion and potential mishandling of test results.

  2. Incorrectly specifying the testing authority or not specifying it at all. Each testing authority has its guidelines and protocols, making this information essential for the test's validity.

  3. Omitting the donor's Social Security Number (SSN) or Employee Identification Number (EIN). This unique identifier is critical for accurately matching the test results with the individual.

  4. Not clearly indicating the reason for the test (e.g., pre-employment, random, post-accident). This specification influences the handling and interpretation of the results.

  5. Selecting the wrong drug tests to be performed or leaving this section blank. This mistake can lead to unnecessary delays or the need for retesting, increasing costs and potentially affecting employment outcomes.

  6. Incomplete information regarding the collection site, such as the name, code, address, or contact details. Accurate site details facilitate proper specimen handling and tracking.

  7. Failure by the collector to remark on the specimen's temperature, an observed collection, or issues with the specimen. Comments provide context that may be crucial for interpreting test results.

  8. Not ensuring that the seal(s) on the specimen bottle(s) are properly affixed, dated, and initialed by the donor. This process safeguards against tampering and maintains the chain of custody integrity.

Each of these errors can lead to significant consequences, including the invalidation of the drug test, delays in processing, or even legal complications. Employers, collectors, and donors must diligently review and accurately complete every section of the Federal Drug Testing Custody and Control Form to uphold the standards of the testing process and the reliability of the results.

Documents used along the form

When it comes to employment and certain regulatory compliance situations, the Federal Drug Testing Custody and Control Form often serves as a critical piece of documentation. However, this form usually doesn't stand alone in the process. Several other forms and documents are commonly used alongside it to ensure a thorough and compliant drug screening process. Below is an overview of such documents, each playing a unique role in the broader context of drug testing and employment.

  • Consent and Release Form: This document is signed by the employee or job applicant, giving their consent to undergo drug testing and authorizing the release of the results to the employer or relevant authorities.
  • Chain of Custody Form: Although part of the Drug Screen Form, it's worth highlighting separately due to its importance in ensuring the specimen's integrity from collection to testing laboratory.
  • Employee Background Check Authorization: Employers often require this form alongside drug testing to conduct a comprehensive background check, which might include criminal records, previous employment verification, and education verification.
  • Medical Review Officer (MRO) Report: An MRO reviews the drug testing results to confirm their accuracy and provides an official report. This document might explain any medical reasons for a positive result.
  • Substance Abuse Professional (SAP) Evaluation Report: If the drug screen is positive, this report details the evaluation and recommendations of a Substance Abuse Professional as required, especially under Department of Transportation (DOT) regulations.
  • Adverse Action Notices: If employment decisions (e.g., not hiring, termination) are made based on the drug test results, employers must provide written notice of the action and the reasons behind it to the affected individual.
  • Employee Assistance Program (EAP) Information: Employers who offer EAPs might include documentation or pamphlets about the program, especially if someone tests positive and seeks help for substance abuse issues.
  • Drug-Free Workplace Policy Acknowledgement: Employees are often required to sign an acknowledgement that they have received, read, and understand the company's drug-free workplace policy.
  • Return-to-Duty Agreement: Following a positive test and completion of prescribed substance abuse treatment or education, this agreement outlines the conditions under which an employee can return to work.

Together, these documents create a comprehensive framework that supports the drug screening process, ensuring not only compliance with regulatory requirements but also fairness and clarity for all parties involved. Employers and employees alike benefit from a well-documented and transparent process that upholds safety, integrity, and legal compliance in the workplace.

Similar forms

  • Employment Application Form: Like the Drug Screen Form, an Employment Application Form collects basic personal information from applicants, such as name, address, and social security number. Both forms are initial steps in assessing a candidate's suitability for a position, with the Drug Screen forming part of the background check process.

  • Medical History Form: This form shares similarities with the Drug Screen Form in that both collect health-related information. The Medical History Form captures a patient’s past medical conditions, while the Drug Screen Form checks for recent drug use, impacting health or job performance.

  • Consent for Treatment Form: Both the Consent for Treatment and the Drug Screen Form involve obtaining an individual's consent before proceeding with a medical-related process. The Drug Screen Form requires the donor's consent for drug testing, similar to how a patient must agree to medical treatment.

  • Background Check Authorization Form: Like the Drug Screen Form, this form is used by employers to conduct background checks on potential or current employees. Both forms are integral to the pre-employment or ongoing employment verification process, ensuring the suitability of the individual for the job.

  • Accident Report Form: Similar to the Drug Screen Form specifying “Post Accident” testing, an Accident Report Form documents the details of a workplace incident. Both are used in situations where an accident has occurred at work, potentially leading to drug testing to determine if substance use was a factor.

  • Return to Duty Form: This form, like the Drug Screen Form specifying “Return to Duty” testing, is used for employees returning to work after a suspension or leave due to policy violations, including failed drug tests. Both forms are steps in ensuring the employee meets the necessary conditions to resume work.

  • Lab Requisition Form: Similar to the Drug Screen Form, a Lab Requisition Form is used to request specific laboratory tests. Both require detailed information about the tests to be performed, the individual’s information, and the requesting authority, ensuring the correct tests are conducted and reported.

  • Chain of Custody Form: Integral to the Drug Screen Form, a Chain of Custody document is also a standalone form used in various legal and medical contexts to track the handling of samples or evidence. Both ensure that the item remains untampered from collection to analysis, maintaining integrity for legal or medical interpretation.

  • Substance Abuse Assessment Form: This form and the Drug Screen Form are used in contexts requiring an understanding of an individual’s drug use. While the Substance Abuse Assessment may provide a broader picture of usage and impact, the Drug Screen offers direct evidence of recent substance use.

Dos and Don'ts

Understanding the complexities and responsibilities when filling out a Federal Drug Testing Custody and Control Form is critical. To ensure the process is completed accurately and ethically, here are nine essential dos and don'ts:

  • Do ensure all personal information is accurate. This includes checking the Employer Name, Address, I.D. No., and the donor’s Social Security Number or Employee I.D. Number for correctness.
  • Do accurately specify the testing authority and the DOT agency if applicable. This is critical for ensuring the test is processed under the correct regulatory framework.
  • Do select the appropriate reason for the test, such as Pre-employment, Random, or Reasonable Suspicion/Cause, to clarify the context of the screening.
  • Do specify precisely which drug tests need to be performed including, but not limited to, THC, COC, PCP, OPI, and AMP. If the required test is not listed, use the 'Other' option to specify.
  • Do ensure that the Collection Site information is filled out completely and accurately. This includes the collection site name, code, address, and the collector's contact information.
  • Don’t leave any fields incomplete unless they are absolutely not applicable to your situation. Incompleteness can lead to delays or the rejection of the form.
  • Don’t guess or estimate information. If you’re unsure about a specific detail, such as the exact drug tests required, seek clarification before submitting the form.
  • Don’t fail to ensure that the specimen collection is observed if required, as failing to do so can compromise the test’s validity.
  • Don’t neglect to review all steps completed by the collector for accuracy and completeness. Mishandling or mislabeling of the specimen could result in testing errors or contamination.

Adherence to these guidelines is paramount in maintaining the integrity of the testing process and ensuring that the results are legally defensible and accurately reflect the sample provided.

Misconceptions

Understanding the nuances of a Federal Drug Testing Custody and Control Form can often lead to misconceptions by both employers and employees due to its complexity. Here are four common misconceptions and clarifications about this form:

  • Privacy Violation: A common misconception is that the drug screen form violates an individual’s privacy by requiring the social security number (SSN) or employee identification number. While the form does request this information for identification purposes, it adheres to strict confidentiality standards set by federal regulations to protect the individual's privacy.
  • Testing Scope: Another misunderstanding relates to the scope of drugs tested. Some believe that if a form specifies certain drugs like THC and COC, it means those are the only substances employers are interested in testing for. However, the form allows customization under section F where other substances can be specified, ensuring a wide range of potential drugs can be screened for based on the employer’s requirements or federal guidelines.
  • Reason for Test: There's also confusion around the reasons for testing. The form includes options such as pre-employment, random, and reasonable suspicion, among others. The misconception lies in the belief that tests are only conducted post-incident or for suspicion. In reality, the form supports a variety of testing purposes, including routine screening to promote a safe work environment.
  • Result Finality: Lastly, there's a misconception that results noted on the form by the initial testing lab are final. If a specimen tests positive, the form facilitates a process for verification or reconfirmation through a split specimen test at another lab, as indicated in section 5b. This ensures the accuracy of the results and provides a fair opportunity for individuals to contest initial findings.

Clarifying these misconceptions helps ensure that individuals and organizations understand the procedural integrity and flexibility built into the Federal Drug Testing Custody and Control Form, promoting its appropriate and effective use.

Key takeaways

When filling out and using the Drug Screen Form, understanding its components and the procedural requirements is essential for accuracy and compliance. Here are six key takeaways to consider:

  • Ensure Accurate Information: Completing the form requires precise information from several parties, including the employer or employer representative, the collector, and the testing laboratories. Confirm that details such as Employer Name, Address, I.D. No., and the donor's Social Security Number or Employee I.D. No. are filled out correctly to prevent any misidentification or delays in the testing process.
  • Specify the Testing Authority and Reason: Clearly marking the testing authority (e.g., DOT, HHS, NRC) and the reason for the test (such as Pre-employment, Random, Reasonable Suspicion Cause) is crucial. This information guides the testing process according to the specific regulatory requirements and ensures the appropriate handling of the sample.
  • Detail on Drugs to be Tested: Indicate clearly which substances will be tested for (THC, COC, PCP, OPI, AMP, etc.). This ensures the laboratory processes the specimen with the correct panel of tests, thus meeting the purpose of the drug screen.
  • Custody and Control: The form acts as a chain of custody document that traces the process from collection to testing, detailing steps such as temperature reading, collection method, and seal integrity. Ensuring each step is accurately completed and recorded on the form is fundamental to the validity of the test.
  • Understanding Test Results: The form provides sections for reporting the test outcomes, including negative, positive for specific substances, dilute, adulterated, substituted, or invalid results. Comprehensive awareness of what each result means is valuable for interpreting the outcomes correctly and deciding on subsequent actions.
  • Compliance with Federal Requirements: The form indicates that the specimen's handling, analysis, and reporting should align with applicable Federal requirements. Adhering to these guidelines is essential for the validity and legal standing of the test results.

Accurate completion and thorough understanding of the Drug Screen Form are vital steps in ensuring the integrity and legality of the drug testing process. This protects the rights of the individuals being tested and supports employers in maintaining a safe and compliant workplace.

Please rate Free Drug Screen PDF Template Form
4.5
Excellent
2 Votes